The association of plasma NT-proBNP level and progression of diabetic kidney disease

Aims Diabetic kidney disease (DKD) is the most common cause of end-stage kidney disease (ESKD). The identification of risk factors involved in the progression of DKD to ESKD is expected to result in early detection and appropriate intervention and improve prognosis. This study aimed to explore wheth...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuancheng Zhao, Lijun Zhao, Yiting Wang, Junlin Zhang, Honghong Ren, Rui Zhang, Yucheng Wu, Yutong Zou, Nanwei Tong, Fang Liu
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Renal Failure
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/0886022X.2022.2158102
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850186870192865280
author Yuancheng Zhao
Lijun Zhao
Yiting Wang
Junlin Zhang
Honghong Ren
Rui Zhang
Yucheng Wu
Yutong Zou
Nanwei Tong
Fang Liu
author_facet Yuancheng Zhao
Lijun Zhao
Yiting Wang
Junlin Zhang
Honghong Ren
Rui Zhang
Yucheng Wu
Yutong Zou
Nanwei Tong
Fang Liu
author_sort Yuancheng Zhao
collection DOAJ
description Aims Diabetic kidney disease (DKD) is the most common cause of end-stage kidney disease (ESKD). The identification of risk factors involved in the progression of DKD to ESKD is expected to result in early detection and appropriate intervention and improve prognosis. This study aimed to explore whether plasma N-terminal pro-B-type natriuretic peptide (NT-proBNP) was associated with kidney outcomes in patients with type 2 diabetes mellitus (T2DM) and biopsy-proven DKD.Methods Patients with biopsy-proven DKD who were followed up at West China Hospital over 12 months were enrolled. The kidney outcome was defined as progression to ESKD. The cutoff value of plasma NT-proBNP concentration was calculated by using receiver operating characteristic (ROC) curve analysis. The influence of NT-proBNP levels on kidney outcome in patients with DKD was assessed using Cox regression analysis.Results A total of 30 (24.5%) patients reached ESKD during a median follow-up of 24.1 months. The baseline serum NT-proBNP level had a significant correlation with baseline proteinuria, kidney function, glomerular lesions, interstitial fibrosis tubular atrophy (IFTA), and arteriolar hyalinosis. Multivariate Cox regression analysis indicated that increased NT-proBNP level was significantly associated with a higher risk of progression to ESKD (HR 6.43; 95% CI (1.65–25.10, p = 0.007), and each 1 SD increase in LG (NT-proBNP) was also associated with a higher risk (HR 2.43; 95% CI 1.94–5.29, p = 0.047) of an adverse kidney outcome after adjusting for confounding factors.Conclusions A higher level of plasma NT-proBNP predicts kidney prognosis in patients with biopsy-proven DKD. This warrants further investigation into the potential mechanisms.
format Article
id doaj-art-b633038007d44e3da0ea928fe564372e
institution OA Journals
issn 0886-022X
1525-6049
language English
publishDate 2023-12-01
publisher Taylor & Francis Group
record_format Article
series Renal Failure
spelling doaj-art-b633038007d44e3da0ea928fe564372e2025-08-20T02:16:14ZengTaylor & Francis GroupRenal Failure0886-022X1525-60492023-12-0145110.1080/0886022X.2022.2158102The association of plasma NT-proBNP level and progression of diabetic kidney diseaseYuancheng Zhao0Lijun Zhao1Yiting Wang2Junlin Zhang3Honghong Ren4Rui Zhang5Yucheng Wu6Yutong Zou7Nanwei Tong8Fang Liu9Division of Nephrology, West China Hospital of Sichuan University, Chengdu, Sichuan ChinaDivision of Nephrology, West China Hospital of Sichuan University, Chengdu, Sichuan ChinaDivision of Nephrology, West China Hospital of Sichuan University, Chengdu, Sichuan ChinaLaboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, Sichuan, ChinaDivision of Nephrology, West China Hospital of Sichuan University, Chengdu, Sichuan ChinaDivision of Nephrology, West China Hospital of Sichuan University, Chengdu, Sichuan ChinaDivision of Nephrology, West China Hospital of Sichuan University, Chengdu, Sichuan ChinaDivision of Nephrology, West China Hospital of Sichuan University, Chengdu, Sichuan ChinaDivision of Endocrinology, West China Hospital of Sichuan University, Chengdu, Sichuan, ChinaDivision of Nephrology, West China Hospital of Sichuan University, Chengdu, Sichuan ChinaAims Diabetic kidney disease (DKD) is the most common cause of end-stage kidney disease (ESKD). The identification of risk factors involved in the progression of DKD to ESKD is expected to result in early detection and appropriate intervention and improve prognosis. This study aimed to explore whether plasma N-terminal pro-B-type natriuretic peptide (NT-proBNP) was associated with kidney outcomes in patients with type 2 diabetes mellitus (T2DM) and biopsy-proven DKD.Methods Patients with biopsy-proven DKD who were followed up at West China Hospital over 12 months were enrolled. The kidney outcome was defined as progression to ESKD. The cutoff value of plasma NT-proBNP concentration was calculated by using receiver operating characteristic (ROC) curve analysis. The influence of NT-proBNP levels on kidney outcome in patients with DKD was assessed using Cox regression analysis.Results A total of 30 (24.5%) patients reached ESKD during a median follow-up of 24.1 months. The baseline serum NT-proBNP level had a significant correlation with baseline proteinuria, kidney function, glomerular lesions, interstitial fibrosis tubular atrophy (IFTA), and arteriolar hyalinosis. Multivariate Cox regression analysis indicated that increased NT-proBNP level was significantly associated with a higher risk of progression to ESKD (HR 6.43; 95% CI (1.65–25.10, p = 0.007), and each 1 SD increase in LG (NT-proBNP) was also associated with a higher risk (HR 2.43; 95% CI 1.94–5.29, p = 0.047) of an adverse kidney outcome after adjusting for confounding factors.Conclusions A higher level of plasma NT-proBNP predicts kidney prognosis in patients with biopsy-proven DKD. This warrants further investigation into the potential mechanisms.https://www.tandfonline.com/doi/10.1080/0886022X.2022.2158102NT-proBNPdiabetic kidney diseasetype 2 diabetes mellitusend-stage kidney disease
spellingShingle Yuancheng Zhao
Lijun Zhao
Yiting Wang
Junlin Zhang
Honghong Ren
Rui Zhang
Yucheng Wu
Yutong Zou
Nanwei Tong
Fang Liu
The association of plasma NT-proBNP level and progression of diabetic kidney disease
Renal Failure
NT-proBNP
diabetic kidney disease
type 2 diabetes mellitus
end-stage kidney disease
title The association of plasma NT-proBNP level and progression of diabetic kidney disease
title_full The association of plasma NT-proBNP level and progression of diabetic kidney disease
title_fullStr The association of plasma NT-proBNP level and progression of diabetic kidney disease
title_full_unstemmed The association of plasma NT-proBNP level and progression of diabetic kidney disease
title_short The association of plasma NT-proBNP level and progression of diabetic kidney disease
title_sort association of plasma nt probnp level and progression of diabetic kidney disease
topic NT-proBNP
diabetic kidney disease
type 2 diabetes mellitus
end-stage kidney disease
url https://www.tandfonline.com/doi/10.1080/0886022X.2022.2158102
work_keys_str_mv AT yuanchengzhao theassociationofplasmantprobnplevelandprogressionofdiabetickidneydisease
AT lijunzhao theassociationofplasmantprobnplevelandprogressionofdiabetickidneydisease
AT yitingwang theassociationofplasmantprobnplevelandprogressionofdiabetickidneydisease
AT junlinzhang theassociationofplasmantprobnplevelandprogressionofdiabetickidneydisease
AT honghongren theassociationofplasmantprobnplevelandprogressionofdiabetickidneydisease
AT ruizhang theassociationofplasmantprobnplevelandprogressionofdiabetickidneydisease
AT yuchengwu theassociationofplasmantprobnplevelandprogressionofdiabetickidneydisease
AT yutongzou theassociationofplasmantprobnplevelandprogressionofdiabetickidneydisease
AT nanweitong theassociationofplasmantprobnplevelandprogressionofdiabetickidneydisease
AT fangliu theassociationofplasmantprobnplevelandprogressionofdiabetickidneydisease
AT yuanchengzhao associationofplasmantprobnplevelandprogressionofdiabetickidneydisease
AT lijunzhao associationofplasmantprobnplevelandprogressionofdiabetickidneydisease
AT yitingwang associationofplasmantprobnplevelandprogressionofdiabetickidneydisease
AT junlinzhang associationofplasmantprobnplevelandprogressionofdiabetickidneydisease
AT honghongren associationofplasmantprobnplevelandprogressionofdiabetickidneydisease
AT ruizhang associationofplasmantprobnplevelandprogressionofdiabetickidneydisease
AT yuchengwu associationofplasmantprobnplevelandprogressionofdiabetickidneydisease
AT yutongzou associationofplasmantprobnplevelandprogressionofdiabetickidneydisease
AT nanweitong associationofplasmantprobnplevelandprogressionofdiabetickidneydisease
AT fangliu associationofplasmantprobnplevelandprogressionofdiabetickidneydisease